[HTML][HTML] Effects of torcetrapib in patients at high risk for coronary events

…, CL Shear, JH Revkin, KA Buhr… - New England journal …, 2007 - Mass Medical Soc
Background Inhibition of cholesteryl ester transfer protein (CETP) has been shown to have
a substantial effect on plasma lipoprotein levels. We investigated whether torcetrapib, a …

Training mentors of clinical and translational research scholars: a randomized controlled trial

…, SC House, P Asquith, MF Fleming, KA Buhr… - Academic …, 2014 - journals.lww.com
Method The authors conducted a randomized controlled trial (RCT) at 16 academic health
centers (June 2010 to July 2011). Faculty mentors of trainees who were conducting clinical/…

Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort

CM Bartels, KA Buhr, JW Goldberg, CL Bell… - The Journal of …, 2014 - jrheum.org
Objective. To examine the mortality and cardiovascular disease (CVD) burden among a
population-based cohort of patients with systemic lupus erythematosus (SLE) with previously …

Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: a …

KK Ray, SJ Nicholls, KA Buhr, HN Ginsberg… - Jama, 2020 - jamanetwork.com
Importance Bromodomain and extraterminal proteins are epigenetic regulators of gene
transcription. Apabetalone is a selective bromodomain and extraterminal protein inhibitor …

Machine learning algorithm predicts cardiac resynchronization therapy outcomes: lessons from the COMPANION trial

…, RT Kipp, MC Tattersall, C Mei, KA Buhr… - Circulation …, 2018 - Am Heart Assoc
Background Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in heart
failure patients with reduced left ventricular function and intraventricular conduction delay. …

Testosterone Treatment and Fractures in Men with Hypogonadism

…, SS Ellenberg, JA Cauley, KA Buhr… - … England Journal of …, 2024 - Mass Medical Soc
Background Testosterone treatment in men with hypogonadism improves bone density and
quality, but trials with a sufficiently large sample and a sufficiently long duration to determine …

[HTML][HTML] Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study

SJ Nicholls, GG Schwartz, KA Buhr… - Cardiovascular …, 2021 - Springer
Background Patients with diabetes and acute coronary syndrome (ACS) are at high risk for
subsequent heart failure. Apabetalone is a selective inhibitor of bromodomain and extra-…

Effect of apabetalone on cardiovascular events in diabetes, CKD, and recent acute coronary syndrome: results from the BETonMACE randomized controlled trial

…, GG Schwartz, SJ Nicholls, KA Buhr… - Clinical Journal of the …, 2021 - journals.lww.com
Results Median follow-up was 27 months (interquartile range, 20–32 months). In participants
with CKD, apabetalone compared with placebo was associated with fewer major adverse …

Relationships between biomechanics, tendon pathology, and function in individuals with lateral epicondylosis

AO Chourasia, KA Buhr, DP Rabago, R Kijowski… - journal of orthopaedic & …, 2013 - jospt.org
… Drs Sesto, Chourasia, and Buhr received support from the University of Wisconsin Clinical
and Translational Science Award (NIH/NCRR 1 UL1RR025011). Dr Rabago was partially …

Widespread incorrect implementation of the Hoffmann method, the correct approach, and modern alternatives

DT Holmes, KA Buhr - American journal of clinical pathology, 2019 - academic.oup.com
Objectives The Hoffmann method is a procedure for reference interval estimation using routine
clinical results. Many authors incorrectly prepare Hoffmann plots on a linear rather than …